Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology

Neurobiology of Disease

Volumn 91, Issue , 2016, Pages 105-123

  Koss, David J ^a   Robinson, Lianne ^a,b   Drever, Benjamin D ^a   Plucińska, Kaja ^a   Stoppelkamp, Sandra ^a,c   Veselcic, Peter ^a,d   Riedel, Gernot ^a   Platt, Bettina ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d ABBVIE INC   (United States)

Author keywords

Anhedonia; Apathy; Cognition; EEG; Frontotemporal dementia; Phosphorylation; Semantic memory; Spatial memory; Tau; Tauopathies

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; TAU PROTEIN;

ANHEDONIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APATHY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CIRCADIAN RHYTHM; COGNITION ASSESSMENT; CONTROLLED STUDY; DEPRESSION; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; ELEVATED PLUS MAZE TEST; FRONTOTEMPORAL DEMENTIA; GENOTYPE; HIPPOCAMPAL SLICE; HISTOPATHOLOGY; LEARNING; MORRIS WATER MAZE TEST; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REM SLEEP; SEMANTIC MEMORY; SUCROSE PREFERENCE TEST; SYNAPTIC TRANSMISSION; ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; GENE KNOCK-IN; GENETICS; LONG TERM POTENTIATION; MEMORY; METABOLISM; NEUROFIBRILLARY TANGLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TAUOPATHY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FRONTOTEMPORAL DEMENTIA; GENE KNOCK-IN TECHNIQUES; LONG-TERM POTENTIATION; MEMORY; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; NEURONAL PLASTICITY; SYNAPTIC TRANSMISSION; TAU PROTEINS; TAUOPATHIES;

EID: 84960921365     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.03.002     Document Type: Article

References (107)

1. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., Atzori C., Migheli A., Crowther R.A., Ghetti B., Spillantini M.G., Goedert M. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 2002, 22(21):9340-9351.
2. Anderson J.M., Hampton D.W., Patani R., Pryce G., Crowther R.A., Reynolds R., Franklin R.J., Giovannoni G., Compston D.A., Baker D., Spillantini M.G., Chandran S. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 2008, 131(Pt 7):1736-1748.
3. Anderson K.N., Hatfield C., Kipps C., Hastings M., Hodges J.R. Disrupted sleep and circadian patterns in frontotemporal dementia. Eur. J. Neurol. 2009, 16(3):317-323.
4. Augustinack J.C., Schneider A., Mandelkow E.M., Hyman B.T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 2002, 103(1):26-35.
5. Baglietto-Vargas D., Kitazawa M., Le E.J., Estrada-Hernandez T., Rodriguez-Ortiz C.J., Medeiros R., Green K.N., Laferla F.M. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition. Neurobiol. Dis. 2014, 62:407-415.
6. Bailey R.M., Howard J., Knight J., Sahara N., Dickson D.W., Lewis J. Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model. Mol. Neurodegener. 2014, 9:8. 10.1186/1750-1326-9-8.
7. Berger Z., Roder H., Hanna A., Carlson A., Rangachari V., Yue M., Wszolek Z., Ashe K., Knight J., Dickson D., Andorfer C., Rosenberry T.L., Lewis J., Hutton M., Janus C. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 2007, 27(14):3650-3662.
8. Bombois S., Derambure P., Pasquier F., Monaca C. Sleep disorders in aging and dementia. J. Nutr. Health Aging 2010, 14(3):212-217.
9. Bonakis A., Economou N.T., Paparrigopoulos T., Bonanni E., Maestri M., Carnicelli L., Di Coscio E., Ktonas P., Vagiakis E., Theodoropoulos P., Papageorgiou S.G. Sleep in frontotemporal dementia is equally or possibly more disrupted, and at an earlier stage, when compared to sleep in Alzheimer's disease. J. Alzheimers Dis. 2014, 38(1):85-91.
10. Bozeat S., Gregory C.A., Ralph M.A., Hodges J.R. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?. J. Neurol. Neurosurg. Psychiatry 2000, 69(2):178-186.
11. Brooks S.P., Pask T., Jones L., Dunnett S.B. Behavioural profiles of inbred mouse strains used as transgenic backgrounds. II: cognitive tests. Genes Brain Behav. 2005, 4(5):307-317.
12. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 2000, 33(1):95-130.
13. Calamai E., Dall'angelo S., Koss D., Domarkas J., McCarthy T.J., Mingarelli M., Riedel G., Schweiger L.F., Welch A., Platt B., Zanda M. 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease. Chem. Commun. 2013, 49(8):792-794.
14. Chiu M.J., Chen T.F., Yip P.K., Hua M.S., Tang L.Y. Behavioral and psychologic symptoms in different types of dementia. J. Formos. Med. Assoc. 2006, 105(7):556-562.
15. Cowan C.M., Bossing T., Page A., Shepherd D., Mudher A. Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol. 2010, 120(5):593-604.
16. Crowther R.A. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(6):2288-2292.
17. De Bruin J.P., Sanchez-Santed F., Heinsbroek R.P., Donker A., Postmes P. A behavioural analysis of rats with damage to the medial prefrontal cortex using the Morris water maze: evidence for behavioural flexibility, but not for impaired spatial navigation. Brain Res. 1994, 652(2):323-333.
18. De Calignon A., Polydoro M., Suarez-Calvet M., William C., Adamowicz D.H., Kopeikina K.J., Pitstick R., Sahara N., Ashe K.H., Carlson G.A., Spires-Jones T.L., Hyman B.T. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73(4):685-697.
19. Deters N., Ittner L.M., Gotz J. Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Eur. J. Neurosci. 2008, 28(1):137-147.
20. Egashira N., Iwasaki K., Takashima A., Watanabe T., Kawabe H., Matsuda T., Mishima K., Chidori S., Nishimura R., Fujiwara M. Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice. Brain Res. 2005, 1059(1):7-12.
21. Farb N.A., Grady C.L., Strother S., Tang-Wai D.F., Masellis M., Black S., Freedman M., Pollock B.G., Campbell K.L., Hasher L., Chow T.W. Abnormal network connectivity in frontotemporal dementia: evidence for prefrontal isolation. Cortex 2013, 49(7):1856-1873.
22. Flament S., Delacourte A. Abnormal tau species are produced during Alzheimer's disease neurodegenerating process. FEBS Lett. 1989, 247(2):213-216.
23. Flunkert S., Hierzer M., Loffler T., Rabl R., Neddens J., Duller S., Schofield E.L., Ward M.A., Posch M., Jungwirth H., Windisch M., Hutter-Paier B. Elevated levels of soluble total and hyperphosphorylated tau result in early behavioral deficits and distinct changes in brain pathology in a new tau transgenic mouse model. Neurodegener. Dis. 2013, 11(4):194-205.
24. Fox L.M., William C.M., Adamowicz D.H., Pitstick R., Carlson G.A., Spires-Jones T.L., Hyman B.T. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model. J. Neuropathol. Exp. Neurol. 2011, 70(7):588-595.
25. Furukawa K., Wang Y., Yao P.J., Fu W., Mattson M.P., Itoyama Y., Onodera H., D'souza I., Poorkaj P.H., Bird T.D., Schellenberg G.D. Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J. Neurochem. 2003, 87(2):427-436.
26. Gama Sosa M.A., De Gasperi R., Elder G.A. Animal transgenesis: an overview. Brain Struct. Funct. 2010, 214(2-3):91-109.
27. Gauthier-Kemper A., Weissmann C., Golovyashkina N., Sebo-Lemke Z., Drewes G., Gerke V., Heinisch J.J., Brandt R. The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner. J. Cell Biol. 2011, 192(4):647-661.
28. Ghosh S., Lippa C.F. Clinical subtypes of frontotemporal dementia. Am. J. Alzheimers Dis. Other Demen. 2015, 30(7):653-661.
29. Gilley J., Seereeram A., Ando K., Mosely S., Andrews S., Kerschensteiner M., Misgeld T., Brion J.P., Anderton B., Hanger D.P., Coleman M.P. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Neurobiol. Aging 2012, 33(3):621.e1-621.e15.
30. Goedert M., Spillantini M.G. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim. Biophys. Acta 2000, 1502(1):110-121.
31. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 1988, 85(11):4051-4055.
32. Goedert M., Ghetti B., Spillantini M.G. Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2(2):a006254.
33. Gotz J., Chen F., Barmettler R., Nitsch R.M. Tau filament formation in transgenic mice expressing P301L tau. J. Biol. Chem. 2001, 276(1):529-534.
34. Guarnieri B., Adorni F., Musicco M., Appollonio I., Bonanni E., Caffarra P., Caltagirone C., Cerroni G., Concari L., Cosentino F.I., Ferrara S., Fermi S., Ferri R., Gelosa G., Lombardi G., Mazzei D., Mearelli S., Morrone E., Murri L., Nobili F.M., Passero S., Perri R., Rocchi R., Sucapane P., Tognoni G., Zabberoni S., Sorbi S. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement. Geriatr. Cogn. Disord. 2012, 33(1):50-58.
35. Harper D.G., Stopa E.G., McKee A.C., Satlin A., Harlan P.C., Goldstein R., Volicer L. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch. Gen. Psychiatry 2001, 58(4):353-360.
36. Hoover B.R., Reed M.N., Su J., Penrod R.D., Kotilinek L.A., Grant M.K., Pitstick R., Carlson G.A., Lanier L.M., Yuan L.L., Ashe K.H., Liao D. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 2010, 68(6):1067-1081.
37. Hrnkova M., Zilka N., Minichova Z., Koson P., Novak M. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats. Brain Res. 2007, 1130(1):206-213.
38. Hunsberger H.C., Rudy C.C., Weitzner D.S., Zhang C., Tosto D.E., Knowlan K., Xu Y., Reed M.N. Effect size of memory deficits in mice with adult-onset P301L tau expression. Behav. Brain Res. 2014, 272:181-195.
39. Hutchinson A.D., Mathias J.L. Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review. J. Neurol. Neurosurg. Psychiatry 2007, 78(9):917-928.
40. Jyoti A., Plano A., Riedel G., Platt B. Progressive age-related changes in sleep and EEG profiles in the PLB1Triple mouse model of Alzheimer's disease. Neurobiol. Aging 2015, 36(10):2768-2784.
41. Khandelwal P.J., Dumanis S.B., Herman A.M., Rebeck G.W., Moussa C.E. Wild type and P301L mutant Tau promote neuro-inflammation and alpha-Synuclein accumulation in lentiviral gene delivery models. Mol. Cell. Neurosci. 2012, 49(1):44-53.
42. Koppel J., Jimenez H., Azose M., D'abramo C., Acker C., Buthorn J., Greenwald B.S., Lewis J., Lesser M., Liu Z., Davies P. Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease. Behav. Brain Res. 2014, 275:27-33.
43. Koss D.J., Drever B.D., Stoppelkamp S., Riedel G., Platt B. Age-dependent changes in hippocampal synaptic transmission and plasticity in the PLB1Triple Alzheimer mouse. Cell. Mol. Life Sci. 2013, 70(14):2585-2601.
44. Koss D.J., Robinson L., Mietelska-Porowska A., Gasiorowska A., Sepcic K., Turk T., Jaspars M., Niewiadomska G., Scott R.H., Platt B., Riedel G. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits. Cell. Mol. Life Sci. 2015, 72(23):4613-4632.
45. Lacroix L., White I., Feldon J. Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav. Brain Res. 2002, 133(1):69-81.
46. Lasagna-Reeves C.A., Castillo-Carranza D.L., Sengupta U., Sarmiento J., Troncoso J., Jackson G.R., Kayed R. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J. 2012, 26(5):1946-1959.
47. Lee S., Jung C., Lee G., Hall G.F. Exonic point mutations of human tau enhance its toxicity and cause characteristic changes in neuronal morphology, tau distribution and tau phosphorylation in the lamprey cellular model of tauopathy. J. Alzheimers Dis. 2009, 16(1):99-111.
48. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X., Duff K., Hardy J., Corral A., Lin W.L., Yen S.H., Dickson D.W., Davies P., Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 2000, 25(4):402-405.
49. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001, 293(5534):1487-1491.
50. Lim F., Hernandez F., Lucas J.J., Gomez-Ramos P., Moran M.A., Avila J. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell. Neurosci. 2001, 18(6):702-714.
51. Lindau M., Jelic V., Johansson S.E., Andersen C., Wahlund L.O., Almkvist O. Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2003, 15(2):106-114.
52. Malloy P., Tremont G., Grace J., Frakey L. The Frontal Systems Behavior Scale discriminates frontotemporal dementia from Alzheimer's disease. Alzheimers Dement. 2007, 3(3):200-203.
53. McMillan P., Korvatska E., Poorkaj P., Evstafjeva Z., Robinson L., Greenup L., Leverenz J., Schellenberg G.D., D'souza I. Tau isoform regulation is region- and cell-specific in mouse brain. J. Comp. Neurol. 2008, 511(6):788-803.
54. Melis V., Zabke C., Stamer K., Magbagbeolu M., Schwab K., Marschall P., Veh R.W., Bachmann S., Deiana S., Moreau P.H., Davidson K., Harrington K.A., Rickard J.E., Horsley D., Garman R., Mazurkiewicz M., Niewiadomska G., Wischik C.M., Harrington C.R., Riedel G., Theuring F. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration. Cell. Mol. Life Sci. 2015, 72(11):2199-2222.
55. Mendez M.F., Shapira J.S., Woods R.J., Licht E.A., Saul R.E. Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement. Geriatr. Cogn. Disord. 2008, 25(3):206-211.
56. Micanovic C., Pal S. The diagnostic utility of EEG in early-onset dementia: a systematic review of the literature with narrative analysis. J. Neural Transm. 2014, 121(1):59-69.
57. Miyasaka T., Morishima-Kawashima M., Ravid R., Heutink P., Van Swieten J.C., Nagashima K., Ihara Y. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. Am. J. Pathol. 2001, 158(2):373-379.
58. Mocanu M.M., Nissen A., Eckermann K., Khlistunova I., Biernat J., Drexler D., Petrova O., Schonig K., Bujard H., Mandelkow E., Zhou L., Rune G., Mandelkow E.M. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 2008, 28(3):737-748.
59. Mourik J.C., Rosso S.M., Niermeijer M.F., Duivenvoorden H.J., Van Swieten J.C., Tibben A. Frontotemporal dementia: behavioral symptoms and caregiver distress. Dement. Geriatr. Cogn. Disord. 2004, 18(3-4):299-306.
60. Murray A.J., Woloszynowska-Fraser M.U., Ansel-Bollepalli L., Cole K.L., Foggetti A., Crouch B., Riedel G., Wulff P. Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility. Sci. Rep. 2015, 5:16778.
61. Nabavi S., Fox R., Proulx C.D., Lin J.Y., Tsien R.Y., Malinow R. Engineering a memory with LTD and LTP. Nature 2014, 511(7509):348-352.
62. Neumann M., Tolnay M., Mackenzie I.R. The molecular basis of frontotemporal dementia. Expert Rev. Mol. Med. 2009, 11:e23.
63. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., Laferla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39(3):409-421.
64. Perri R., Monaco M., Fadda L., Caltagirone C., Carlesimo G.A. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study. J. Alzheimers Dis. 2014, 39(3):669-677.
65. Petry F.R., Pelletier J., Bretteville A., Morin F., Calon F., Hebert S.S., Whittington R.A., Planel E. Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. PLoS One 2014, 9(5):e94251.
66. Platt B., Riedel G. The cholinergic system, EEG and sleep. Behav. Brain Res. 2011, 221(2):499-504.
67. Platt B., Drever B., Koss D., Stoppelkamp S., Jyoti A., Plano A., Utan A., Merrick G., Ryan D., Melis V., Wan H., Mingarelli M., Porcu E., Scrocchi L., Welch A., Riedel G. Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS One 2011, 6(11):e27068.
68. Platt B., Welch A., Riedel G. FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease. Biochem. Soc. Trans. 2011, 39(4):874-880.
69. Plucinska K., Crouch B., Koss D., Robinson L., Siebrecht M., Riedel G., Platt B. Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes. J. Neurosci. 2014, 34(32):10710-10728.
70. Podhorna J., Brown R.E. Strain differences in activity and emotionality do not account for differences in learning and memory performance between C57BL/6 and DBA/2 mice. Genes Brain Behav. 2002, 1(2):96-110.
71. Polydoro M., Acker C.M., Duff K., Castillo P.E., Davies P. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. J. Neurosci. 2009, 29(34):10741-10749.
72. Polydoro M., Dzhala V.I., Pooler A.M., Nicholls S.B., McKinney A.P., Sanchez L., Pitstick R., Carlson G.A., Staley K.J., Spires-Jones T.L., Hyman B.T. Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model. Acta Neuropathol. 2014, 127(2):257-270.
73. Porter V.R., Buxton W.G., Fairbanks L.A., Strickland T., O'connor S.M., Rosenberg-Thompson S., Cummings J.L. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J. Neuropsychiatr. Clin. Neurosci. 2003, 15(2):180-186.
74. Rabinovici G.D., Seeley W.W., Kim E.J., Gorno-Tempini M.L., Rascovsky K., Pagliaro T.A., Allison S.C., Halabi C., Kramer J.H., Johnson J.K., Weiner M.W., Forman M.S., Trojanowski J.Q., Dearmond S.J., Miller B.L., Rosen H.J. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am. J. Alzheimers Dis. Other Demen. 2007, 22(6):474-488.
75. Ramsden M., Kotilinek L., Forster C., Paulson J., McGowan E., Santacruz K., Guimaraes A., Yue M., Lewis J., Carlson G., Hutton M., Ashe K.H. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J. Neurosci. 2005, 25(46):10637-10647.
76. Rascovsky K., Salmon D.P., Hansen L.A., Thal L.J., Galasko D. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology 2007, 21(1):20-30.
77. Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., Van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., Hillis A.E., Josephs K.A., Boeve B.F., Kertesz A., Seeley W.W., Rankin K.P., Johnson J.K., Gorno-Tempini M.L., Rosen H., Prioleau-Latham C.E., Lee A., Kipps C.M., Lillo P., Piguet O., Rohrer J.D., Rossor M.N., Warren J.D., Fox N.C., Galasko D., Salmon D.P., Black S.E., Mesulam M., Weintraub S., Dickerson B.C., Diehl-Schmid J., Pasquier F., Deramecourt V., Lebert F., Pijnenburg Y., Chow T.W., Manes F., Grafman J., Cappa S.F., Freedman M., Grossman M., Miller B.L. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134(Pt 9):2456-2477.
78. Robinson L., Riedel G. Comparison of automated home-cage monitoring systems: emphasis on feeding behaviour, activity and spatial learning following pharmacological interventions. J. Neurosci. Methods 2014, 234:13-25.
79. Robinson L., Plano A., Cobb S., Riedel G. Long-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice. Behav. Brain Res. 2013, 250:148-156.
80. Rogers T.T., Ivanoiu A., Patterson K., Hodges J.R. Semantic memory in Alzheimer's disease and the frontotemporal dementias: a longitudinal study of 236 patients. Neuropsychology 2006, 20(3):319-335.
81. Rosenmann H., Grigoriadis N., Eldar-Levy H., Avital A., Rozenstein L., Touloumi O., Behar L., Ben-Hur T., Avraham Y., Berry E., Segal M., Ginzburg I., Abramsky O. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Exp. Neurol. 2008, 212(1):71-84.
82. Ryan D., Koss D., Porcu E., Woodcock H., Robinson L., Platt B., Riedel G. Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent. Cell. Mol. Life Sci. 2013, 70(14):2603-2619.
83. Sahara N., Deture M., Ren Y., Ebrahim A.S., Kang D., Knight J., Volbracht C., Pedersen J.T., Dickson D.W., Yen S.H., Lewis J. Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. J. Alzheimers Dis. 2013, 33(1):249-263.
84. Salomons A.R., Bronkers G., Kirchhoff S., Arndt S.S., Ohl F. Behavioural habituation to novelty and brain area specific immediate early gene expression in female mice of two inbred strains. Behav. Brain Res. 2010, 215(1):95-101.
85. Salomons A.R., Arndt S.S., Ohl F. Impact of anxiety profiles on cognitive performance in BALB/c and 129P2 mice. Cogn. Affect. Behav. Neurosci. 2012, 12(4):794-803.
86. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., Deture M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309(5733):476-481.
87. Scattoni M.L., Gasparini L., Alleva E., Goedert M., Calamandrei G., Spillantini M.G. Early behavioural markers of disease in P301S tau transgenic mice. Behav. Brain Res. 2010, 208(1):250-257.
88. Schindowski K., Bretteville A., Leroy K., Begard S., Brion J.P., Hamdane M., Buee L. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am. J. Pathol. 2006, 169(2):599-616.
89. Spittaels K., Van Den Haute C., Van Dorpe J., Bruynseels K., Vandezande K., Laenen I., Geerts H., Mercken M., Sciot R., Van Lommel A., Loos R., Van Leuven F. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am. J. Pathol. 1999, 155(6):2153-2165.
90. Stopford C.L., Thompson J.C., Neary D., Richardson A.M., Snowden J.S. Working memory, attention, and executive function in Alzheimer's disease and frontotemporal dementia. Cortex 2012, 48(4):429-446.
91. Stozicka Z., Zilka N., Novak P., Kovacech B., Bugos O., Novak M. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease. J. Neuroinflammation 2010, 7:64. 10.1186/1742-2094-7-64.
92. Tackenberg C., Brandt R. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J. Neurosci. 2009, 29(46):14439-14450.
93. Takeuchi H., Iba M., Inoue H., Higuchi M., Takao K., Tsukita K., Karatsu Y., Iwamoto Y., Miyakawa T., Suhara T., Trojanowski J.Q., Lee V.M., Takahashi R. P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS One 2011, 6(6):e21050.
94. Tanemura K., Akagi T., Murayama M., Kikuchi N., Murayama O., Hashikawa T., Yoshiike Y., Park J.M., Matsuda K., Nakao S., Sun X., Sato S., Yamaguchi H., Takashima A. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol. Dis. 2001, 8(6):1036-1045.
95. Tanemura K., Murayama M., Akagi T., Hashikawa T., Tominaga T., Ichikawa M., Yamaguchi H., Takashima A. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J. Neurosci. 2002, 22(1):133-141.
96. Tartaglia M.C., Hu B., Mehta K., Neuhaus J., Yaffe K., Miller B.L., Boxer A. Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 2014, 28(2):182-189.
97. Tatebayashi Y., Miyasaka T., Chui D.H., Akagi T., Mishima K., Iwasaki K., Fujiwara M., Tanemura K., Murayama M., Ishiguro K., Planel E., Sato S., Hashikawa T., Takashima A. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(21):13896-13901.
98. Terwel D., Lasrado R., Snauwaert J., Vandeweert E., Van Haesendonck C., Borghgraef P., Van Leuven F. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J. Biol. Chem. 2005, 280(5):3963-3973.
99. Van der Jeugd A., Ahemd T., Burnouf S., Belarbi K., Hamdame M., Grosjean M.E., Humez S., Balschun D., Blum D., Buee L., D'Hooge R. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol. Learn. Mem. 2011, 95(3):296-304.
100. Van Der Jeugd A., Blum D., Raison S., Eddarkaoui S., Buee L., D'hooge R. Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia. Behav. Brain Res. 2013, 242:34-39.
101. Van Der Kooij M.A., Sandi C. Social memories in rodents: methods, mechanisms and modulation by stress. Neurosci. Biobehav. Rev. 2012, 36(7):1763-1772.
102. Vogelsberg-Ragaglia V., Bruce J., Richter-Landsberg C., Zhang B., Hong M., Trojanowski J.Q., Lee V.M. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol. Biol. Cell 2000, 11(12):4093-4104.
103. Wessel J.R., Ullsperger M., Obrig H., Villringer A., Quinque E., Schroeter M.L., Bretschneider K.J., Arelin K., Roggenhofer E., Frisch S., Klein T.A. Neural synchrony indexes impaired motor slowing after errors and novelty following white matter damage. Neurobiol. Aging 2016, 38:205-213.
104. Whitlock J.R., Heynen A.J., Shuler M.G., Bear M.F. Learning induces long-term potentiation in the hippocampus. Science 2006, 313(5790):1093-1097.
105. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53(3):337-351.
106. Zamboni G., Huey E.D., Krueger F., Nichelli P.F., Grafman J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology 2008, 71(10):736-742.
107. Zhang B., Higuchi M., Yoshiyama Y., Ishihara T., Forman M.S., Martinez D., Joyce S., Trojanowski J.Q., Lee V.M. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J. Neurosci. 2004, 24(19):4657-4667.